New anesthesia drug aims to make kidney stone surgery less painful
NCT ID NCT07659132
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study compares a newer anesthesia drug, fospropofol disodium, with the standard drug propofol for people undergoing ureteroscopy (a procedure to remove kidney stones). About 190 adults will be randomly assigned to receive one of the two drugs during surgery. The main goal is to see which drug leads to higher patient satisfaction 24 hours after the procedure, and to check for side effects like injection pain or heart issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fospropofol disodium
- What this could lead to
- If fospropofol works better, it could offer a smoother anesthesia experience with less injection pain for people having ureteroscopy.
- What could go wrong
- This is a small, single-center trial that hasn't started yet. Results may not apply to other surgeries or populations, and fospropofol may not prove superior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA FOR UROLOGIC ENDOSCOPIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.